Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
»
1-min read

British Drug-maker, Indivior, Shares Rise After US Court Blocks Dr.Reddy's Rival Generic Drug

Dr Reddy's, though, has said it would launch its new drug regardless of the legal squabble.

Reuters

Updated:June 18, 2018, 2:44 PM IST
facebookTwitterskypewhatsapp
British Drug-maker, Indivior, Shares Rise After US Court Blocks Dr.Reddy's Rival Generic Drug
Representative Image
Loading...

London: Shares in British drugmaker Indivior rose on Monday after a US Court granted a temporary restraining order blocking Dr. Reddy's Laboratories from launching a generic version of Indivior's best-selling opioid addiction treatment.

Indivior shares rose more than 6 percent in early trade, after falling by nearly a third on Friday after Dr Reddy's and US-based Mylan NV received FDA approval for a generic version of Suboxone Film, which generates 80 percent of Indivior's revenue.

Indivior said on Saturday that the US District Court for the District of New Jersey granted it a temporary restraining order, which will remain in place pending a hearing on the preliminary injunction motion filed by Indivior on Friday.

"We are pleased that the Court has granted our request for a temporary restraining order. We will continue to pursue all legal avenues against Dr. Reddy's to protect our Suboxone Film patent," Indivior Chief Executive Shaun Thaxter said.

A hearing on the preliminary injunction motion has been scheduled for June 28, and the company will seek to extend the cessation of launch activities by Dr. Reddy's pending the outcome of the recently filed litigation against Dr Reddy's.

Dr Reddy's said on Friday it would launch its new drug regardless of the legal squabble.

Generic rivals in tablet form are already on the US market, which is grappling with an opioid addiction epidemic that killed 33,000 people in 2015, but Suboxone Film leads the market with its version which is placed under the tongue to suppress cravings.

Indivior stuck to its 2018 revenue guidance on Friday but said it would revisit the forecast if Dr. Reddy's launches the cheaper drug.

It said Dr. Reddy's launch could 'potentially result in a rapid and material loss of market share for the drug in the US, an effect that could occur within months of a successful launch of a generic film alternative.'

Indivior also said it was considering a potential launch of its own generic and operational cost cuts in response. It said its contingency plans would also focus on optimising the launch of Sublocade, a once-a-month injectable drug to suppress opioid craving that it launched in the United States in February.​

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months. Use code FREEDOM.

Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp
Most Active
Company Price Change %Gain
Indiabulls Hsg 550.75 -0.11
HDFC 2,100.00 -0.84
Reliance 1,278.00 -0.80
Yes Bank 79.45 3.79
HDFC Bank 2,227.70 -0.08
Company Price Change %Gain
SBI 290.95 0.38
Indiabulls Hsg 551.10 -0.04
Yes Bank 79.45 3.79
Maruti Suzuki 5,975.15 2.74
SpiceJet 143.50 3.02
Top Gainers
Company Price Change %Gain
UPL 549.05 4.14
Yes Bank 79.45 3.79
Power Grid Corp 211.15 2.92
Maruti Suzuki 5,975.05 2.73
IndusInd Bank 1,439.10 2.73
Company Price Change %Gain
Yes Bank 79.45 3.79
Power Grid Corp 211.25 2.85
Maruti Suzuki 5,975.15 2.74
IndusInd Bank 1,438.25 2.70
Axis Bank 675.55 1.86
Top Losers
Company Price Change %Gain
TCS 2,165.10 -1.78
Vedanta 144.40 -1.47
HCL Tech 1,062.75 -1.25
BPCL 351.20 -0.92
HDFC 2,100.00 -0.84
Company Price Change %Gain
TCS 2,163.50 -1.87
Vedanta 144.30 -1.54
HCL Tech 1,061.65 -1.37
HDFC 2,098.75 -0.91
Reliance 1,277.40 -0.85

Live TV

Loading...
Countdown To Elections Results
To Assembly Elections 2018 Results